Table 2.
Results of cumulative probability P values regarding different parametric data.
| Ranks | Response rate | Adverse event | Overall survival | |||||
|---|---|---|---|---|---|---|---|---|
| Interventions (P) | Specific agents (P) | Interventions (P) | Specific agents (P) | Interventions (P) | Specific agents (P) | |||
| Rank 1 | Anthracycline + Mitomycin + Pyrimidine (P=0.45) | Doxorubicin + Mitomycin + Gemcitabine(P=0.49) | Anthracycline + Mitomycin + Pyrimidine (P=0.32) | Doxorubicin + Mitomycin + Gemcitabine(P=0.37) | Anthracycline + Mitomycin + Pyrimidine (P=0.35) | Doxorubicin + Mitomycin + Gemcitabine(P=0.77) | ||
| Rank 2 | Ethanol (P=0.31) | Ethanol (P=0.34) | Ethanol (P=0.22) | Ethanol (P=0.25) | Platinum + Anthracycline + Mitomycin (P=0.28) | Epirubicin + Lobaplatin + Mitomycin (P=0.07) | ||
| Rank 3 | Platinum + Anthracycline + Mitomycin (P=0.22) | Epirubicin + Lobaplatin + Mitomycin(P=0.15) | Raltitrexed (P=0.21) | Raltitrexed (P=0.13) | Ethanol (P=0.20) | Ethanol (P=0.07) | ||
| Rank 4 | Anthracycline + Mitomycin (P=0.02) | Doxorubicin + Mitomycin(P=0.02) | Pyrimidine(P=0.20) | Pyrimidine(P=0.10) | Raltitrexed (P=0.15) | Raltitrexed (P=0.03) | ||
| Rank 5 | — | — | Platinum + Anthracycline + Mitomycin + Pyrimidine(P=0.02) | Fluorouracil(P=0.03) | Anthracycline + Mitomycin (P=0.01) | Epirubicin + Cisplatin + Mitomycin + Furuorouracil(P=0.03) | ||